Cargando…
Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose: Correspondence
Autores principales: | Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388162/ https://www.ncbi.nlm.nih.gov/pubmed/35988973 http://dx.doi.org/10.1016/j.anai.2022.05.030 |
Ejemplares similares
-
Split-dosing of coronavirus disease 2019 vaccines
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Antibody response to the messenger RNA corona virus disease 2019 vaccine in liver transplant recipients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Messenger RNA vaccines and neutralizing anti–severe acute respiratory syndrome coronavirus 2 antibodies in patients with immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021) -
Willingness to Pay for a Coronavirus Vaccine: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)